en

PRODUCT DETAIL

Reseligo 3,6 mg

Code 9370B
MA number 44/0258/16-S
Product Form: imp sip 3x3,6 mg (aplik.inj.ihl.+implantát)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Decentralised
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L02 ENDOCRINE THERAPY
L02A HORMONES AND RELATED AGENTS
L02AE Gonadotropin releasing hormone analogues
L02AE03 Goserelin
Shelf life: 48
Container: needle applicator
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(3) hybrid application
Pediatric warnings: Yes
PIL: PIL_Reseligo 3,6 mg_imp sip_04/2021.pdf  
SPC: SPC_Reseligo 3,6 mg_imp sip_04/2021.pdf  
Safety feature Yes
Data update: 26.04.2023
eu-flag.png sk-flag.png